Number of the records: 1  

Combination of LINE-1 hypomethylation and RASSF1A promoter hypermethylation in serum DNA is a non-invasion prognostic biomarker for early recurrence of hepatocellular carcinoma after curative resection

  1. Combination of LINE-1 hypomethylation and RASSF1A promoter hypermethylation in serum DNA is a non-invasion prognostic biomarker for early recurrence of hepatocellular carcinoma after curative resection / Z. J. Liu ... [et al.]. -- ilustr., grafy, tab. -- Bibliogr. odkazy

    In Neoplasma : journal of experimental and clinical oncology. -- Bratislava : AEPress, 2017. -- s. 641-808. -- ISSN 0028-2685. -- Vol. 64, no. 5 (2017), s. 795-802

    1. karcinóm hepatocelulárny - chirurgia - genetika - krv 2. gény supresorové nádorové 3. oblasti promótorové, v genetike 4. metylácia DNA 5. recidíva nádoru, lokálna 6. biomarkery nádorové 7. analýza prežívania 8. prognóza

    I. Liu, Z. J.
    II. Neoplasma : journal of experimental and clinical oncology. -- Vol. 64, no. 5 (2017), s. 795-802

    LINE-1 hypometylácia - RASSF1A hypermetylácia
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.